Revista Clínica Española (English Edition)

ISSN: 2254-8874

Revista Clínica Española published its first issue in 1940 and is the body of expression of the Spanish Society of Internal Medicine (SEMI).
The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Revista Clínica Española is subject to a thorough double blind review of the received articles written in Spanish or English. Ten issues are published each year, including mostly originals, reviews and consensus documents.

Indexed in:

Scopus, Medline

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.3

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

0.7

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.162

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.211

View more metrics

Open Access Option

Journal Information

Special content about coronavirus SARS-CoV-2 (COVID-19) in Revista Clínica Española (English Edition)

Solving one of the pieces of the puzzle: COVID-19 and type 2 diabetes

P. Pérez-Martínez, F.J. Carrasco Sánchez, J. Carretero Gómez, R. Gómez-Huelgas

10.1016/j.rceng.2020.05.004

Rev Clin Esp. 2020;220:507-10

Inflammation, malnutrition, and SARS-CoV-2 infection: A disastrous combination

J. Carretero Gómez, M.C. Mafé Nogueroles, F. Garrachón Vallo, E Escudero Álvarez, E. Maciá Botejara, J.P. Miramontes González

10.1016/j.rceng.2020.07.006

Rev Clin Esp. 2020;220:511-7

Recurrent positive SARS-CoV-2 RNA tests in recovered and discharged patients

Z.S. Ulhaq, G.V. Soraya, F.A. Fauziah

10.1016/j.rceng.2020.06.005

Rev Clin Esp. 2020;220:524-6

Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment

R. Boixeda, L. Campins, J. Juanola, L. Force

10.1016/j.rceng.2020.07.004

Rev Clin Esp. 2020;220:526-9

COVID-19 and Argumentum ad ignorantiam or “not everything goes”

M.L. López Reboiro, C. Sardiña González, J. López Castro

10.1016/j.rceng.2020.04.007

Rev Clin Esp. 2020;220:457

Ivermectin in COVID-19. Argumentun ad ignorantiam ?

Y. Carlosama-Rosero

10.1016/j.rceng.2020.06.003

Rev Clin Esp. 2020;220:457-8

Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam ?

M.L. López Reboiro, C. Sardiña González, J. López Castro

10.1016/j.rceng.2020.06.004

Rev Clin Esp. 2020;220:458

Pulmonary embolism and COVID-19: A paradigm change

A. Franco-Moreno, N. Muñoz-Rivas, B. Mestre-Gómez, J. Torres-Macho

10.1016/j.rceng.2020.05.007

Rev Clin Esp. 2020;220:459-61

Whether to make decisions "on the fly" regarding treatment for SARS-CoV-2 infection

V. Abril López de Medrano, E. Merino de Lucas, M. Salavert Lletí

10.1016/j.rceng.2020.07.002

Rev Clin Esp. 2020;220:461-2

Comorbidity in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction. Cluster analysis of the RICA registry. Opportunities for improvement

J.C. Arévalo Lorido, J. Carretero Gómez, R. Gómez Huelgas, R. Quirós López, M.F. Dávila Ramos, A. Serrado Iglesias, F. Ruiz Laiglesia, A. González Franco, J.M. Cepeda Rodrigo, M. Montero-Pérez-Barquero

10.1016/j.rceng.2019.10.008

Rev Clin Esp. 2020;220:409-16

Previous 8 9 10 Page 11 12 13 14 Next

Indexed in:

Follow us:

Subscribe:

Special content about coronavirus SARS-CoV-2 (COVID-19) in Revista Clínica Española (English Edition)

Subscribe to our newsletter